Filing Details
- Accession Number:
- 0000912282-24-000172
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-02-21 11:55:02
- Reporting Period:
- 2024-02-16
- Accepted Time:
- 2024-02-21 11:55:02
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1509261 | Rezolute Inc. | RZLT | Pharmaceutical Preparations (2834) | 273440894 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1829608 | Kenneth Brian Roberts | C/O Rezolute, Inc. 275 Shoreline Drive, Suite 500 Redwood City CA 94065 | Chief Medical Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Acquisiton | 2024-02-16 | 7,000 | $1.31 | 34,552 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The purchase price reported above is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.295 to $1.320, inclusive. The reporting person undertakes to provide to Rezolute, Inc., any security holder of Rezolute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
Billionaire Hedge Funds
